Tower Research Capital LLC (TRC) - VIRPAX PHARMACEUTICALS INC ownership

VIRPAX PHARMACEUTICALS INC's ticker is VRPX and the CUSIP is 928251107. A total of 16 filers reported holding VIRPAX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of VIRPAX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$4,976
-15.2%
6,220
+14.5%
0.00%
Q2 2023$5,868
+146600.0%
5,433
-0.5%
0.00%
Q1 2023$4
+33.3%
5,463
+6.5%
0.00%
Q4 2022$3
-99.9%
5,130
+14.4%
0.00%
Q3 2022$5,000
+25.0%
4,486
+72.4%
0.00%
Q2 2022$4,000
+100.0%
2,602
+304.7%
0.00%
Q4 2021$2,0006430.00%
Other shareholders
VIRPAX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 988,165$614,9350.54%
Quantum Private Wealth, LLC 10,000$6,2230.00%
Warberg Asset Management LLC 17,012$10,5610.00%
Belpointe Asset Management LLC 19,045$11,8520.00%
OSAIC HOLDINGS, INC. 600$00.00%
PNC FINANCIAL SERVICES GROUP, INC. 100,875$62,7440.00%
WELLS FARGO & COMPANY/MN 59$370.00%
NORTHERN TRUST CORP 15,221$9,4720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 66,038$410.00%
View complete list of VIRPAX PHARMACEUTICALS INC shareholders